---
title: Psychedelic therapy in depression and substance use disorders
date: '2024-05-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38773750/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240522182830&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Psychoactive substances obtained from botanicals have been applied for
  a wide variety of purposes in the rituals of different cultures for thousands of
  years. Classical psychedelics from N,N'-dimethyltryptamine, psilocybin, mescaline
  and various lysergamides cause specific alterations in perception, emotion and cognition
  by acting through serotonin 5-HT(2A) receptor activation. Lysergic acid diethylamide,
  the first famous breakthrough in the field, was discovered by chance by Albert Hoffman
  ...
disable_comments: true
---
Psychoactive substances obtained from botanicals have been applied for a wide variety of purposes in the rituals of different cultures for thousands of years. Classical psychedelics from N,N'-dimethyltryptamine, psilocybin, mescaline and various lysergamides cause specific alterations in perception, emotion and cognition by acting through serotonin 5-HT(2A) receptor activation. Lysergic acid diethylamide, the first famous breakthrough in the field, was discovered by chance by Albert Hoffman ...